Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy

被引：29

作者：

Gori, Niccolo ^{[1
,2
]}

Chiricozzi, Andrea ^{[1
,2
]}

Malvaso, Dalma ^{[1
,2
]}

D'Urso, Dario Francesco ^{[1
,2
]}

Caldarola, Giacomo ^{[2
]}

De Simone, Clara ^{[1
,2
]}

Peris, Ketty ^{[1
,2
]}

机构：

[1] Fdn Policlin Univ A Gemelli IRCCS, UOC Dermatol, Largo Agostino Gemelli 8, LT-00618 Rome, Italy

[2] Univ Cattolica Sacro Cuore, Rome, Italy

来源：

DERMATOLOGY | 2021年 / 237卷 / 04期

关键词：

Atopic dermatitis; Dupilumab; Systemic therapy; Phototherapy; EUROPEAN GUIDELINES; ADULTS; MODERATE;

D O I：

10.1159/000512890

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Background: Dupilumab, a monoclonal antibody inhibiting the signaling pathway of IL-4/IL-13, was shown to be safe and effective in the treatment of moderate/severe atopic dermatitis (AD) in several clinical trials and real-life experiences, with only a small percentage of patients showing to be resistant or to lose disease control. Objectives: In this study, we investigated the effectiveness and safety in combining dupilumab with systemic agents or phototherapy in patients experiencing an inadequate response to dupilumab. Methods: This retrospective, monocentric, observational study consecutively included patients aged >18 years, with moderate-severe AD, under treatment with dupilumab. In this cohort of patients, we analyzed data of subjects who experienced an inadequate response to dupilumab, even when combined with topical corticosteroids, and for whom an additional systemic treatment or phototherapy was combined to dupilumab. Results: In this study, we included a total population of 69 patients treated with dupilumab. In 12/69 patients (17.4%) showing an inadequate response to dupilumab, a combined treatment consisting of dupilumab plus methylprednisolone (n = 5), cyclosporine (n = 4), methotrexate (n = 2), or narrow band-UVB (n = 1) was administered. Overall, after 8 weeks of combined therapy, the majority of patients (11 of 12) obtained an improvement of signs and symptoms of AD. Patients treated with combined therapy did not experience any adverse events, neither did they withdraw treatment because of the occurrence of adverse events. Conclusions: This study suggests that the combination of dupilumab with a conventional drug or phototherapy may represent a valid therapeutic choice, maintaining a good safety profile in AD patients recalcitrant to dupilumab monotherapy.

引用

页码：535 / 541

页数：7

共 18 条

[1] Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis [J].

Beck, Lisa A. ;

Thaci, Diamant ;

Hamilton, Jennifer D. ;

Graham, Neil M. ;

Bieber, Thomas ;

Rocklin, Ross ;

Ming, Jeffrey E. ;

Ren, Haobo ;

Kao, Richard ;

Simpson, Eric ;

Ardeleanu, Marius ;

Weinstein, Steven P. ;

Pirozzi, Gianluca ;

Guttman-Yassky, Emma ;

Suarez-Farinas, Mayte ;

Hager, Melissa D. ;

Stahl, Neil ;

Yancopoulos, George D. ;

Radin, Allen R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02) :130-139

[2] Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial [J].

Blauvelt, Andrew ;

de Bruin-Weller, Marjolein ;

Gooderham, Melinda ;

Cather, Jennifer C. ;

Weisman, Jamie ;

Pariser, David ;

Simpson, Eric L. ;

Papp, Kim A. ;

Hong, H. Chih-Ho ;

Rubel, Diana ;

Foley, Peter ;

Prens, Errol ;

Griffiths, Christopher E. M. ;

Etoh, Takafumi ;

Pinto, Pedro Herranz ;

Pujol, Ramon M. ;

Szepietowski, Jacek C. ;

Ettler, Karel ;

Kemeny, Lajos ;

Zhu, Xiaoping ;

Akinlade, Bolanle ;

Hultsch, Thomas ;

Mastey, Vera ;

Gadkari, Abhijit ;

Eckert, Laurent ;

Amin, Nikhil ;

Graham, Neil M. H. ;

Pirozzi, Gianluca ;

Stahl, Neil ;

Yancopoulos, George D. ;

Shumel, Brad .

LANCET, 2017, 389 (10086) :2287-2303

[3] Current therapeutic paradigm in pediatric atopic dermatitis: Practical guidance from a national expert panel [J].

Chiricozzi, A. ;

Fortina, A. Belloni ;

Galli, E. ;

Girolomoni, G. ;

Neri, I. ;

Ricci, G. ;

Romanelli, M. ;

Peroni, D. .

ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2019, 47 (02) :194-206

[4] Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo [J].

Chiricozzi, Andrea ;

Maurelli, Martina ;

Gori, Niccolo ;

Argenziano, Giuseppe ;

De Simone, Clara ;

Calabrese, Giulia ;

Girolomoni, Giampiero ;

Peris, Ketty .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) :39-45

[5] Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy [J].

D'Erme, Angelo Massimiliano ;

Romanelli, Marco ;

Chiricozzi, Andrea .

DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 :1473-1480

[6] Italian guidelines for therapy of atopic dermatitis-Adapted from consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) [J].

Damiani, Giovanni ;

Calzavara-Pinton, Piergiacomo ;

Stingeni, Luca ;

Hansel, Katharina ;

Cusano, Francesco ;

Pigatto, Paolo D. M. ;

Agostinelli, D. ;

Albertazzi, D. ;

Angelini, G. ;

Angerosa, F. ;

Arigliano, P. L. ;

Assalve, D. ;

Ayala, F. ;

Barbagallo, T. ;

Belloni-Fortina, A. ;

Berta, M. ;

Biale, C. ;

Bianchi, L. ;

Biasini, I. ;

Boccaletti, V. ;

Bonamonte, D. ;

Borghi, A. ;

Bragazzi, N. L. ;

Brambilla, L. ;

Bressan, M. ;

Brunasso, A. M. G. ;

Bruni, F. ;

Bruni, P. ;

Caccavalle, S. ;

Calogiuri, G. ;

Cannavo, S. P. ;

Carugno, A. ;

Cataldi, I. ;

Chiarelli, G. ;

Cirla, A. M. ;

Corazza, M. ;

Cossutta, M. ;

Cova, L. ;

Cristaudo, A. ;

Cusano, F. ;

Danese, P. ;

Dal Canton, M. ;

De Pita, O. ;

De Salvo, P. ;

Donini, M. ;

Fantini, F. ;

Ferrucci, S. M. ;

Flori, M. L. ;

Fontana, E. ;

Foti, C. .

DERMATOLOGIC THERAPY, 2019, 32 (06)

[7] Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data [J].

de Wijs, L. E. M. ;

Bosma, A. L. ;

Erler, N. S. ;

Hollestein, L. M. ;

Gerbens, L. A. A. ;

Middelkamp-Hup, M. A. ;

Kunkeler, A. C. M. ;

Nijsten, T. E. C. ;

Spuls, P. I. ;

Hijnen, D. J. .

BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (02) :418-426

[8] A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis [J].

Fargnoli, M. C. ;

Esposito, M. ;

Ferrucci, S. ;

Girolomoni, G. ;

Offidani, A. ;

Patrizi, A. ;

Peris, K. ;

Costanzo, A. ;

Malara, G. ;

Pellacani, G. ;

Romanelli, M. ;

Amerio, P. ;

Cristaudo, A. ;

Flori, M. L. ;

Motolese, A. ;

Betto, P. ;

Patruno, C. ;

Pigatto, P. ;

Peccianti, C. ;

Stinco, G. ;

Zalaudek, I. ;

Bianchi, L. ;

Boccaletti, V. ;

Cannavo, S. P. ;

Cusano, F. ;

Lembo, S. ;

Mozzillo, R. ;

Gallo, R. ;

Potenza, C. ;

Rongioletti, F. ;

Tiberio, R. ;

Grieco, T. ;

Micali, G. ;

Persechino, S. ;

Pettinato, M. ;

Pucci, S. ;

Stingeni, L. ;

Caruso, C. ;

Argenziano, G. .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) :1146-1149

[9] Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis [J].

Fargnoli, M. C. ;

Esposito, M. ;

Ferrucci, S. ;

Girolomoni, G. ;

Offidani, A. ;

Patrizi, A. ;

Peris, K. ;

Costanzo, A. ;

Malara, G. ;

Pellacani, G. ;

Romanelli, M. ;

Amerio, P. ;

Cristaudo, A. ;

Flori, M. L. ;

Motolese, A. ;

Betto, P. ;

Patruno, C. ;

Pigatto, P. ;

Sirna, R. ;

Stinco, G. ;

Zalaudek, I. ;

Bianchi, L. ;

Boccaletti, V. ;

Cannavo, S. P. ;

Cusano, F. ;

Lembo, S. ;

Mozzillo, R. ;

Gallo, R. ;

Potenza, C. ;

Rongioletti, F. ;

Tiberio, R. ;

Grieco, T. ;

Micali, G. ;

Persechino, S. ;

Pettinato, M. ;

Pucci, S. ;

Savi, E. ;

Stingeni, L. ;

Romano, A. ;

Argenziano, G. ;

Calabrese, Giulia ;

Campanati, Anna ;

Caruso, Cristiano ;

Chello, Camilla ;

De Pasquale, Tiziana ;

Di Costanzo, Luisa ;

Dini, Valentina ;

De Pasquale, Rocco ;

Del Giglio, Micol ;

Fracassi, Giovanna .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (05) :507-513

[10] Narrowband UVB phototherapy in skin conditions beyond psoriasis [J].

Gambichler, T ;

Breuckmann, F ;

Boms, S ;

Altmeyer, P ;

Kreuter, A .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (04) :660-670

← 1 2 →